The only patented * assay targeting the core of the molecule (145-245), Cisbio’s Chromoa R assay offers exceptional sensitivity, specificity, and reproducibility by using two monoclonal antibodies to measure intact and fragmented Chromogranin A (CgA).This enhances the reliability of results. Chromogranin A measurements in neuroendocrine tumors are established in the guidelines** as an aid for diagnosis, treatment efficiency and prognostic factors. Developed under a sandwich-type ELISA format, Chromoa R is simple to use and can be easily adapted to automated systems for implementation in laboratories of all sizes. *EP1078266,US 6,632,624 ** Guidelines